Maat Pharma SA
PAR:MAAT
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.92
9.6
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Maat Pharma SA
Total Current Liabilities
Maat Pharma SA
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Maat Pharma SA
PAR:MAAT
|
Total Current Liabilities
€11.5m
|
CAGR 3-Years
59%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
Valneva SE
PAR:VLA
|
Total Current Liabilities
€102.5m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
21%
|
CAGR 10-Years
15%
|
|
Nanobiotix SA
PAR:NANO
|
Total Current Liabilities
€49.9m
|
CAGR 3-Years
38%
|
CAGR 5-Years
34%
|
CAGR 10-Years
31%
|
|
Innate Pharma SA
PAR:IPH
|
Total Current Liabilities
€38.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
12%
|
|
Genfit SA
NASDAQ:GNFT
|
Total Current Liabilities
€38.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
16%
|
|
Eurobio Scientific SA
PAR:ALERS
|
Total Current Liabilities
€52.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
17%
|
CAGR 10-Years
18%
|
See Also
What is Maat Pharma SA's Total Current Liabilities?
Total Current Liabilities
11.5m
EUR
Based on the financial report for Dec 31, 2023, Maat Pharma SA's Total Current Liabilities amounts to 11.5m EUR.
What is Maat Pharma SA's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
39%
Over the last year, the Total Current Liabilities growth was 25%. The average annual Total Current Liabilities growth rates for Maat Pharma SA have been 59% over the past three years , 39% over the past five years .